Author:
Ezzeddine Fatima M.,Killu Ammar M.,Deshmukh Abhishek J.,Munoz Freddy Del-Carpio
Publisher
Springer Science and Business Media LLC
Subject
Physiology (medical),Cardiology and Cardiovascular Medicine
Reference8 articles.
1. Knops RE, Olde Nordkamp LRA, Delnoy PHM, Boersma LVA, Kuschyk J, El-Chami MF, et al. Subcutaneous or transvenous defibrillator therapy. N Engl J Med. 2020;383(6):526–36.
2. Ochman AR, Riesbeck M, Corbisiero R. Inappropriate shock caused by P- and T-wave oversensing in a subcutaneous implantable cardiac defibrillator in a patient in sinus rhythm. Heart Rhythm Case Rep. 2021;7(7):433–5.
3. Mulder BA, Maass AH, Blaauw Y. Inappropriate shock caused by P wave oversensing in an entirely subcutaneous ICD. Neth Heart J. 2018;26(7–8):411–2.
4. Karnik AA, Helm RH, Monahan KM. Oversensing of atrial fibrillatory waves in a subcutaneous implantable cardioverter-defibrillator. Heart Rhythm Case Rep. 2017;3(4):e1–6.
5. Chang SC, Patton KK, Robinson MR, Poole JE, Prutkin JM. Subcutaneous ICD screening with the Boston Scientific ZOOM programmer versus a 12-lead ECG machine. Pacing Clin Electrophysiol. 2018;41(5):511–6.